Subject: 500AC
Location: Zone 56
Gender: Female
Height: 5 foot 6 inches
Weight: 6 stone 10
Hair: black
Eyes: green
Abnormalities:
- Wrist stamp, left arm.
- Several burn marks evident on upper and lower torso.
- Cominnuted fracture of the left tibia.
Conclusion: No major defects evident that could negatively impact study.
Approval for case file number: 79:20:NZ
Approval granted by Agent Francesc
Medic Report for case file 79:20:NZ
Initial report: Subject responded well to procedure. Visible burns and minor lacerations noted in pre-op were superficial and had no impact on surgery
Operation proceeded as expected and complied with the guidelines submitted to and approved by the supervisory committee.
Subject 500AC is the first person to undergo treatment using Substance Q. As such, detailed analysis of the treatment has been recorded and collected by the supervisory committee.
This medic report is for general personnel with appropriate clearance. It is to be used for training and quality control purposes.
Week One (after the initial operation): Subject 500AC has responded well to the augmentations. No visible rejection has occurred. Subject is still under complete sedation, as per supervisory committee order #17. All life signs are normal.
Week Two: Sedation has been alleviated and subject 500AC has begun to respond to stimulus. Eye movement, blinking and facial twitches have been witnessed in response to auditory and visual stimuli.
Week Three: Subject has begun to communicate. No prior knowledge to her entry to the facility has been displayed. Further testing is needed to verify whether this is the result of Substance Q or due to the accident that caused the previous injuries (see Abnormalities).
There is a progressive development of sensation from the head to the upper torso. The lower torso is still paralyzed.
Week 4: Full movement has been regained in the upper body. The lower body shows signs of sensation. Blood and urine tests have returned with expected results. The program is moving along as planned. Complete recovery due within original timeframe.
Month 3: Pain killers were administered when subject displayed discomfort in areas localized around the augmentations. The amount and frequency of the extra medication affected data collection and had to be reduced.
Subject became aggressive and appropriate sedatives were administered. Subject was then restrained in accordance with supervisory committee order #74 in order to evaluate project status.
A second operation was required to examine the full extent of damage. Erosion had occurred between the connective tissues, presumably due to underdeveloped Substance Q.
Case file 79:20:NZ has been delayed until further notice.